https://www.selleckchem.com/pr....oducts/remodelin.htm
A selection of new drugs in advanced development for ER+/HER2- breast cancer will be discussed in this review.Concurrent cisplatin-based chemotherapy and radiotherapy (CCRT) plus brachytherapy is standard treatment for locally advanced cervical cancer. Platinum-based neoadjuvant chemotherapy (NACT) followed by radical hysterectomy has been proposed as an alternative approach, especially for patients with stage Ib2-IIb disease. This review analyzes the most commonly used combination regimens in this clinical setting and the randomized
Like
Comment
Share
